Join to View Full Profile
4350 La Jolla Village DrSte 800San Diego, CA 92122
Phone+1 858-251-3490
Dr. Theuer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Los Angeles County-Harbor-UCLA Medical CenterResidency, Surgery, 1989 - 1996
University of California San Francisco School of MedicineClass of 1989
Certifications & Licensure
CA State Medical License 1990 - 2026
Clinical Trials
- Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN) Start of enrollment: 2016 Mar 01
- Study of TRC105 + Paclitaxel/Carboplatin and Bevacizumab in Patients With NSCLC Start of enrollment: 2015 Sep 01
- Study of TJ004309 in Combination With Atezolizumab (Tecentriq®) in Patients With Advanced or Metastatic Cancer Start of enrollment: 2019 Jul 16
Publications & Presentations
PubMed
- Anti-Endoglin monoclonal antibody prevents the progression of liver sinusoidal endothelial inflammation and fibrosis in MASH.Samira Eissazadeh, Petra Fikrova, Jana Urbankova Rathouska, Ivana Nemeckova, Katarina Tripska
Life Sciences. 2025-03-01 - 3 citationsEndoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis.Teresa González-Muñoz, Angela Di Giannatale, Susana García-Silva, Vanesa Santos, Sara Sánchez-Redondo
Clinical Cancer Research. 2023-09-15 - 6 citationsEndoglin inhibitor TRC105 with or without bevacizumab for bevacizumab-refractory glioblastoma (ENDOT): a multicenter phase II trial.Manmeet S Ahluwalia, Lisa R Rogers, Rekha Chaudhary, Herbert Newton, Ahmad Ozair
Communications Medicine. 2023-09-08
Press Mentions
TRACON Pharmaceuticals to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech SummitSeptember 13th, 2021- TRACON Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment ConferenceSeptember 7th, 2021
- TRACON Pharmaceuticals to Present at the Wells Fargo Virtual Healthcare ConferenceSeptember 2nd, 2021
- Join now to see all
Grant Support
- Genetic Epidemiology Of Gastric CancerNational Cancer Institute1998–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
